‹

News & Bulletin UpdatesNews

INDIA DOMESTIC PRICES – WHAT IS GOING ON?

C5 edges higher in Ahmedabad as steady monthly recovery approaches resistance – India Domestic Prices – What Is Going On?

IndianPetroChem

This edition covers:

  • Methanol jumps sharply in Mumbai as weekly gains reinforce monthly recovery momentum
  • DMF edges higher as powerful monthly rally reaches fresh domestic market peak
  • IPA s urges in Chennai as sharp weekly rebound reshapes market direction
  • Benzene rallies in Vizag as strong fortnightly gains lift domestic market sentiment
  • Ethyl acetate extends decline as Ahmedabad prices retreat toward monthly support levels
  • Nitrobenzene climbs in Delhi as powerful monthly gains reinforce firm market momentum
  • Acrylamide retreats from yearly peak but broader monthly recovery remains firmly intact
  • C5 edges higher in Ahmedabad as steady monthly recovery approaches resistance
  • Maleic anhydride rebounds sharply in Mumbai as monthly recovery regains momentum
  • Phthalic anhydride hits one-year high as powerful Mumbai rally accelerates further
  • Palm wax tumbles sharply but remains above last month’s domestic price level
  • Sulphuric acid edges higher in Ankleshwar as monthly gains remain firmly intact
  • Hydrogen peroxide rebounds strongly in Delhi as fortnightly market recovery gains momentum
  • Heavy soda ash extends Ahmedabad decline as monthly weakness pressures market sentiment
  • Mancozeb rebounds sharply this week but remains below monthly market benchmark levels
  • Monostearin climbs steadily in Mumbai as fortnightly gains strengthen market positioning
  • PP climbs in Mumbai as steady monthly gains reinforce domestic market strength
  • PBT holds firm near yearly high as Ahmedabad market consolidates recent gains
  • ABS rises in Ahmedabad as steady monthly recovery reaches fresh market highs

The complete bulletin is available to subscribers.

Read the complete bulletin

Request a free trial and our team will set up your access. Subscribers log in and return to this bulletin in full.

Questions about access? Contact our team
← Browse more news & analysis